{"version":"1.0","provider_name":"Vigilant Biosciences\u00ae\u00ae sviluppa metodi avanzati e accurati per facilitare il rilevamento precoce del tumore orale identificando diversi biomarcatori unici che si sono dimostrati associati al tumore orale. Scopra come questa tecnologia salvavita pu\u00f2 fare la differenza per i suoi pazienti.","provider_url":"https:\/\/vigilantbiosciences.com\/it","author_name":"Wendy Vrijenhoek","author_url":"https:\/\/vigilantbiosciences.com\/it\/author\/wendy-vrijenhoek\/","title":"Dan DeSmit - Vigilant Biosciences\u00ae","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"pctnPxk3JE\"><a href=\"https:\/\/vigilantbiosciences.com\/it\/dipl-team-member\/dan-desmit\/\">Dan DeSmit<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/vigilantbiosciences.com\/it\/dipl-team-member\/dan-desmit\/embed\/#?secret=pctnPxk3JE\" width=\"600\" height=\"338\" title=\"&#8220;Dan DeSmit&#8221; &#8212; Vigilant Biosciences\u00ae\" data-secret=\"pctnPxk3JE\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/vigilantbiosciences.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/Desmit_720x720.jpg","thumbnail_width":720,"thumbnail_height":720,"description":"Dan DeSmit joined Vigilant Biosciences\u00ae in December 2021 and serves as Director of New Product Introduction, leading end-to-end engineering development of the BeVigilant\u2122 OraFusion\u2122 System. He brings over 15 years of medical device experience spanning mechanical, chemical, electrical, and software development, and has directed multiple design transfers across the United States and Asia. Dan previously [&hellip;]"}